UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 18, 2020
_____________________
InfuSystem Holdings, Inc.
(Exact name of registrant as specified in its charter)
_________________________
Delaware |
001-35020 |
20-3341405 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
3851 West Hamlin Road
Rochester Hills, Michigan 48309
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (248) 291-1210
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
___________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities Registered Pursuant to Section 12(b) of the Act:
Title of Each Class |
Trading Symbol(s) |
Name of Each Exchange on which Registered |
Common Stock, par value $0.0001 per share |
INFU |
NYSE American LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. Regulation FD.
On May 18, 2020, InfuSystem Holdings, Inc. (the “Company”) issued a press release announcing that Richard DiIorio, the Company’s Chief Executive Officer and Barry Steele, the Company’s Chief Financial Officer, will present at the Lytham Partners Virtual Investor Conference on Wednesday, May 20, 2020 at 1:00 p.m. ET. The press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information furnished in this Item 7.01 — “Regulation FD Disclosure” of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 shall not be deemed “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of such section, and shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. |
Description |
99.1 |
Press Release of InfuSystem Holdings, Inc. dated May 18, 2020. |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
INFUSYSTEM HOLDINGS, INC. |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Barry Steele |
|
|
|
Barry Steele |
|
|
|
Chief Financial Officer |
|
Dated: May 18, 2020
Exhibit 99.1
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 |
FOR IMMEDIATE RELEASE
CONTACT: |
Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 |
InfuSystem to Present at Lytham Partners Virtual Investor Conference
Investor Presentation to be held 1:00 p.m. Eastern Time
Rochester Hills, Michigan, May 18, 2020 – InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Richard DiIorio, Chief Executive Officer and Barry Steele, Chief Financial Officer, will present at the Lytham Partners Virtual Investor Conference on Wednesday, May 20, 2020 at 1:00 p.m. ET.
A webcast of the presentation will be posted under the investor relations section of InfuSystem’s website at www.infusystem.com or can be accessed at https://www.webcaster4.com/Webcast/Page/1698/34757. A replay of the presentation will be available following the event.
Management will also be participating in virtual one-on-one meetings on Thursday, May 21, 2020. To arrange a meeting, please contact Joe Dorame of Lytham Partners at dorame@lythampartners.com or visit www.lythampartners.com/virtual.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion pumps and related durable medical equipment support services to hospitals, clinics and other alternate site healthcare providers. Headquartered in Rochester Hills, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Massachusetts and Ontario, Canada. The Company’s stock is traded on the NYSE American under the symbol INFU.
Forward-Looking Statements
Certain statements contained in this press release or made in the virtual conference are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, business plans, objectives and prospects, future operating or financial performance. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “strategy,” “future,” “likely,” variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. Forward-looking statements are subject to factors, risks and uncertainties that could cause actual results to differ materially, including, but not limited to, our dependence on estimates of collectible revenue, potential litigation, changes in third-party reimbursement processes, changes in law and other risk factors disclosed in the Company’s most recent annual report on Form 10-K and, to the extent applicable, quarterly reports on Form 10-Q. All forward-looking statements made in this press release speak only as of the date hereof. We do not undertake any obligation to update any forward-looking statements to reflect future events or circumstances, except as required by law.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
# # #
/($.*'$FRI,F3*%.J7,FRI7_?"P
MQTL)E-H/$.@\EQI@&:'&1_30%U]W+^_E&(%3YK2N:8/%>_!T#\>%U:X:U6.$
MNW$9+)#*'%D\W\4MHYUQ2]$,4]50;HNWB=@'WZGE U-CM-TRJ6'_O22R4-W6
M7>!1.2T5)?-E2U/29E4L'K#1<-U0L]U"H%;>%T$S8F80T T2C%#%)U50W34V
MR=HN12,:5>+Q+-&1V